Zygmont Chester Stanley III bought REVB

January 8, 2026 · Form 4 insider transaction

Zygmont Chester Stanley III bought 78,145 shares of Revelation Biosciences, Inc. at $0.90 per share, a transaction worth $70.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
78,145
Price
$0.90
Total value
$70.3K
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 8, 2026
Filing dateJanuary 12, 2026
Shares owned after473,790
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant.; Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.

View the original Form 4 on SEC EDGAR